Regulation of cyclin D2 and the cyclin D2 promoter by protein kinase A and CREB in lymphocytes

被引:40
作者
White, PC
Shore, AM
Clement, M
McLaren, J
Soeiro, I
Lam, EWF
Brennan, P
机构
[1] Cardiff Univ, Cardiff CF14 4XX, Wales
[2] Canc Res UK Labs, London, England
[3] Hammersmith Hosp, Imperial Coll Sch Med, Sect Canc Cell Biol, London, England
关键词
cyclin D2; phosphatidylinositol; 3-kinase; CREB; interelukin-2; Epstein-Barr virus;
D O I
10.1038/sj.onc.1209255
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lymphocyte proliferation is key to the regulation of the immune system. Cyclin D2 is the first cell cycle protein induced following stimulation through the T-cell receptor, the B-cell receptor or cytokines. The promoter of this cyclin integrates a diverse range of signals. Through investigating the regulation of this promoter by interleukin-2 and phosphatidylinositol 3-kinase, we have identified a role for the transcription factor CREB, cAMP response element-binding protein. Mutation of the CREB-binding site reduced cyclin D2 promoter activity 5-10-fold. CREB-1 is phosphorylated at serine 133, a critical site for activity, in both T cells and Epstein Barr virus immortalized B cells. The introduction of an S133A mutant of CREB-1 reduces IL-2 induction of cyclin D2 promoter activity, demonstrating a role for this phosphorylation site in promoter activity. Two inhibitors of protein kinase A reduce lymphocyte proliferation and CREB-1 phosphorylation. This study demonstrates that the cyclin D2 promoter is capable of being regulated by PI3K and CREB and identifies CREB-1 and protein kinase A as potential targets for altering lymphocyte proliferation.
引用
收藏
页码:2170 / 2180
页数:11
相关论文
共 39 条
  • [1] AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113
  • [2] CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression
    Appleman, LJ
    Berezovskaya, A
    Grass, I
    Boussiotis, VA
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (01) : 144 - 151
  • [3] BCR signals target p27Kip1 and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells
    Banerji, L
    Glassford, J
    Lea, NC
    Thomas, NSB
    Klaus, GGB
    Lam, EWF
    [J]. ONCOGENE, 2001, 20 (50) : 7352 - 7367
  • [4] Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB
    Barton, K
    Muthusamy, N
    Chanyangam, M
    Fischer, C
    Clendenin, C
    Leiden, JM
    [J]. NATURE, 1996, 379 (6560) : 81 - 85
  • [5] ACTIVATION OF JAK KINASES AND STAT PROTEINS BY INTERLEUKIN-2 AND INTERFERON-ALPHA, BUT NOT THE T-CELL ANTIGEN RECEPTOR, IN HUMAN T-LYMPHOCYTES
    BEADLING, C
    GUSCHIN, D
    WITTHUHN, BA
    ZIEMIECKI, A
    IHLE, JN
    KERR, IM
    CANTRELL, DA
    [J]. EMBO JOURNAL, 1994, 13 (23) : 5605 - 5615
  • [6] Belkowski SM, 1998, J IMMUNOL, V161, P659
  • [7] Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
    Brennan, P
    Babbage, JW
    Burgering, BMT
    Groner, B
    Reif, K
    Cantrell, DA
    [J]. IMMUNITY, 1997, 7 (05) : 679 - 689
  • [8] Inhibition of NFkappaB activity by oxidative processes in intact cells - Mechanism of action of pyrolidine dithiocarbamate and diamide.
    Brennan, P
    ONeill, LAJ
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (01) : S3 - S3
  • [9] Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells
    Brennan, P
    Mehl, AM
    Jones, M
    Rowe, M
    [J]. ONCOGENE, 2002, 21 (08) : 1263 - 1271
  • [10] LY294002 and rapamycin co-operate to inhibit T-cell proliferation
    Breslin, EM
    White, PC
    Shore, AM
    Clement, M
    Brennan, P
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (06) : 791 - 800